Groundbreaking HIV cure study in South Africa shows the safety and potential efficacy of a novel therapeutic regimen in women ...
A pioneering study at UKZN has demonstrated that 20% of HIV patients in the trial remained off antiretroviral therapy while ...
Almost half of women in Africa will be obese or overweight by 2030, according to a new study, an "alarming rise" that has ...
In a moment of both triumph and uncertainty, South Africa's scientific community has unveiled encouraging results from a landmark HIV cure trial conducted in Durban, KwaZulu-Natal. The University of ...
Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...
Recent research co-authored by Professor Linda-Gail Bekker from the University of Cape Town (UCT) showed that withdrawing the US President’s Emergency Plan for AIDS Relief (PEPFAR) support in South ...
More than 40,000 previously unknown gut microbes in African populations could completely change how medicines work for ...
The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...
well-tolerated and 100% effective at preventing HIV among cisgender adolescent girls and young women as young as 16 years old in South Africa and Uganda. A phase 3 trial found lenacapavir was safe ...